TABLE 3

Percent Adherence With Aims Using Random Intercept Binomial Regression Models

AimBaseline, Percent Adherence, (95% CI)6 Months (End of Active Period), Percent Adherence, (95% CI)Baseline Versus 6 Months, Wald’s Test, P12 Months (Sustainability Period), Percent Adherence, (95% CI)6 Months Versus 12 Months, Wald’s Test, P
Diagnosis of children with genetic disorders
 Family histories are created/maintained at health supervision visits documenting all components6% (2–16)60% (32–83)<.00180% (52–93).007
 Current family histories are discussed with patient/family, both positives and negatives78% (67–86)80% (70–88).5175% (60–86).3
Management of children with genetic disorders
 Patients with genetic disorders have up to date age-appropriate health supervision visits70% (58–79)77% (67–85)<.00189% (83–93)<.001
 Patients with specific genetic disorders that have existing disorder-specific health supervision guidelines receive the specified care162458% (23–81)85% (72–92)<.00199% (97–100)<.001
 Patients with genetic disorders have next steps of care and planned follow-up14% (3–44)47% (15–81)<.00176% (39–94)<.001
 Patients with genetic disorders are offered genetic services at least initially38% (16–66)18% (9–41)<.00136% (15–64)<.001
 Patients with genetic disorders older than 11 y old receive resources and discussion about transition to adult care at least annually4% (1–17)5% (1–17).467% (2–17).006
  • CI, confidence interval